Novo Nordisk Series B shares gain 2.1% Friday
Novo Nordisk A/S Series B shares rose 2.1% on Friday, outperforming the OMX Nordic 40 Index’s 1.5% gain.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Novo Nordisk A/S Series B shares rose 2.1% on Friday, outperforming the OMX Nordic 40 Index’s 1.5% gain.